# Acurx Pharmaceuticals, Inc.: Form 8-K, filed Nov 15, 2023

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: 8-K
- Filed: 2023-11-15
- Accepted by EDGAR: Nov 15, 2023, 17:02 ET
- Period: 2023-11-15
- Accession: 0001104659-23-118749
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465923118749/tm2330856d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465923118749/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465923118749/tm2330856d1_8k.htm

Filed Nov 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-118749. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.